Cargando…

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada

We aimed to determine whether early public health interventions in 2020 mitigated the association of sociodemographic and clinical risk factors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a population-based cohort study of all adults in Ontario, Canada w...

Descripción completa

Detalles Bibliográficos
Autores principales: Udell, Jacob A., Behrouzi, Bahar, Sivaswamy, Atul, Chu, Anna, Ferreira-Legere, Laura E., Fang, Jiming, Goodman, Shaun G., Ezekowitz, Justin A., Bainey, Kevin R., van Diepen, Sean, Kaul, Padma, McAlister, Finlay A., Bogoch, Isaac I., Jackevicius, Cynthia A., Abdel-Qadir, Husam, Wijeysundera, Harindra C., Ko, Dennis T., Austin, Peter C., Lee, Douglas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232511/
https://www.ncbi.nlm.nih.gov/pubmed/35750706
http://dx.doi.org/10.1038/s41598-022-13598-z
_version_ 1784735600211918848
author Udell, Jacob A.
Behrouzi, Bahar
Sivaswamy, Atul
Chu, Anna
Ferreira-Legere, Laura E.
Fang, Jiming
Goodman, Shaun G.
Ezekowitz, Justin A.
Bainey, Kevin R.
van Diepen, Sean
Kaul, Padma
McAlister, Finlay A.
Bogoch, Isaac I.
Jackevicius, Cynthia A.
Abdel-Qadir, Husam
Wijeysundera, Harindra C.
Ko, Dennis T.
Austin, Peter C.
Lee, Douglas S.
author_facet Udell, Jacob A.
Behrouzi, Bahar
Sivaswamy, Atul
Chu, Anna
Ferreira-Legere, Laura E.
Fang, Jiming
Goodman, Shaun G.
Ezekowitz, Justin A.
Bainey, Kevin R.
van Diepen, Sean
Kaul, Padma
McAlister, Finlay A.
Bogoch, Isaac I.
Jackevicius, Cynthia A.
Abdel-Qadir, Husam
Wijeysundera, Harindra C.
Ko, Dennis T.
Austin, Peter C.
Lee, Douglas S.
author_sort Udell, Jacob A.
collection PubMed
description We aimed to determine whether early public health interventions in 2020 mitigated the association of sociodemographic and clinical risk factors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a population-based cohort study of all adults in Ontario, Canada who underwent testing for SARS-CoV-2 through December 31, 2020. The outcome was laboratory-confirmed SARS-CoV-2 infection, determined by reverse transcription polymerase chain reaction testing. Adjusted odds ratios (ORs) were determined for sociodemographic and clinical risk factors before and after the first-wave peak of the pandemic to assess for changes in effect sizes. Among 3,167,753 community-dwelling individuals, 142,814 (4.5%) tested positive. The association between age and SARS-CoV-2 infection risk varied over time (P-interaction < 0.0001). Prior to the first-wave peak, SARS-CoV-2 infection increased with age whereas this association reversed thereafter. Risk factors that persisted included male sex, residing in lower income neighborhoods, residing in more racially/ethnically diverse communities, immigration to Canada, hypertension, and diabetes. While there was a reduction in infection rates after mid-April 2020, there was less impact in regions with higher racial/ethnic diversity. Immediately following the initial peak, individuals living in the most racially/ethnically diverse communities with 2, 3, or ≥ 4 risk factors had ORs of 1.89, 3.07, and 4.73-fold higher for SARS-CoV-2 infection compared to lower risk individuals in their community (all P < 0.0001). In the latter half of 2020, this disparity persisted with corresponding ORs of 1.66, 2.48, and 3.70-fold higher, respectively. In the least racially/ethnically diverse communities, there was little/no gradient in infection rates across risk strata. Further efforts are necessary to reduce the risk of SARS-CoV-2 infection among the highest risk individuals residing in the most racially/ethnically diverse communities.
format Online
Article
Text
id pubmed-9232511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92325112022-06-26 Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada Udell, Jacob A. Behrouzi, Bahar Sivaswamy, Atul Chu, Anna Ferreira-Legere, Laura E. Fang, Jiming Goodman, Shaun G. Ezekowitz, Justin A. Bainey, Kevin R. van Diepen, Sean Kaul, Padma McAlister, Finlay A. Bogoch, Isaac I. Jackevicius, Cynthia A. Abdel-Qadir, Husam Wijeysundera, Harindra C. Ko, Dennis T. Austin, Peter C. Lee, Douglas S. Sci Rep Article We aimed to determine whether early public health interventions in 2020 mitigated the association of sociodemographic and clinical risk factors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a population-based cohort study of all adults in Ontario, Canada who underwent testing for SARS-CoV-2 through December 31, 2020. The outcome was laboratory-confirmed SARS-CoV-2 infection, determined by reverse transcription polymerase chain reaction testing. Adjusted odds ratios (ORs) were determined for sociodemographic and clinical risk factors before and after the first-wave peak of the pandemic to assess for changes in effect sizes. Among 3,167,753 community-dwelling individuals, 142,814 (4.5%) tested positive. The association between age and SARS-CoV-2 infection risk varied over time (P-interaction < 0.0001). Prior to the first-wave peak, SARS-CoV-2 infection increased with age whereas this association reversed thereafter. Risk factors that persisted included male sex, residing in lower income neighborhoods, residing in more racially/ethnically diverse communities, immigration to Canada, hypertension, and diabetes. While there was a reduction in infection rates after mid-April 2020, there was less impact in regions with higher racial/ethnic diversity. Immediately following the initial peak, individuals living in the most racially/ethnically diverse communities with 2, 3, or ≥ 4 risk factors had ORs of 1.89, 3.07, and 4.73-fold higher for SARS-CoV-2 infection compared to lower risk individuals in their community (all P < 0.0001). In the latter half of 2020, this disparity persisted with corresponding ORs of 1.66, 2.48, and 3.70-fold higher, respectively. In the least racially/ethnically diverse communities, there was little/no gradient in infection rates across risk strata. Further efforts are necessary to reduce the risk of SARS-CoV-2 infection among the highest risk individuals residing in the most racially/ethnically diverse communities. Nature Publishing Group UK 2022-06-24 /pmc/articles/PMC9232511/ /pubmed/35750706 http://dx.doi.org/10.1038/s41598-022-13598-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Udell, Jacob A.
Behrouzi, Bahar
Sivaswamy, Atul
Chu, Anna
Ferreira-Legere, Laura E.
Fang, Jiming
Goodman, Shaun G.
Ezekowitz, Justin A.
Bainey, Kevin R.
van Diepen, Sean
Kaul, Padma
McAlister, Finlay A.
Bogoch, Isaac I.
Jackevicius, Cynthia A.
Abdel-Qadir, Husam
Wijeysundera, Harindra C.
Ko, Dennis T.
Austin, Peter C.
Lee, Douglas S.
Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title_full Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title_fullStr Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title_full_unstemmed Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title_short Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
title_sort clinical risk, sociodemographic factors, and sars-cov-2 infection over time in ontario, canada
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232511/
https://www.ncbi.nlm.nih.gov/pubmed/35750706
http://dx.doi.org/10.1038/s41598-022-13598-z
work_keys_str_mv AT udelljacoba clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT behrouzibahar clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT sivaswamyatul clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT chuanna clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT ferreiralegerelaurae clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT fangjiming clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT goodmanshaung clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT ezekowitzjustina clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT baineykevinr clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT vandiepensean clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT kaulpadma clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT mcalisterfinlaya clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT bogochisaaci clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT jackeviciuscynthiaa clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT abdelqadirhusam clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT wijeysunderaharindrac clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT kodennist clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT austinpeterc clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada
AT leedouglass clinicalrisksociodemographicfactorsandsarscov2infectionovertimeinontariocanada